Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Kronos Bio Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	56.53	38.69	28.64	36.43	58.66	36.41
Short-Term Investments	83.91	88.8	152.72	225.04	211.67	203.04
Cash & Short-Term Investments	140.44	127.49	181.37	261.47	270.33	239.45
Cash Growth	-21.34%	-29.70%	-30.64%	-3.28%	12.90%	-18.61%
Accounts Receivable	245.99	255.72	257.35	255.05	269.91	260
Other Receivables	0.97	0.41	1.97	2.56	2.3	3.43
Receivables	246.96	256.13	259.32	257.61	272.21	263.43
Inventory	446.64	493.2	493.72	482.29	464.18	444.38
Other Current Assets	56.23	62.69	66.02	61.79	68.21	143.03
Total Current Assets	890.27	939.52	1,000	1,063	1,075	1,090
Property, Plant & Equipment	1,434	1,473	1,501	1,480	1,371	1,365
Other Intangible Assets	1.13	1.22	1.36	1.51	1.68	1.18
Total Assets	2,326	2,414	2,503	2,545	2,447	2,456
Accounts Payable	8.34	7.16	6.99	6.9	6.25	6.54
Accrued Expenses	23.05	11.85	12.43	16.25	15.28	14.74
Short-Term Debt	37.79	47.71	55.84	91.01	29.14	26.68
Current Portion of Leases	1.07	1.18	1.42	2.34	5.67	5.72
Current Income Taxes Payable	-	5.45	7.9	19.03	30.63	104.82
Other Current Liabilities	0.21	0.82	1.62	2.59	1.52	1.33
Total Current Liabilities	70.46	74.16	86.19	138.11	88.48	159.84
Long-Term Leases	2.6	3.44	4.6	5.75	7.9	13.28
Long-Term Deferred Tax Liabilities	81.08	80.68	77.86	75.68	80.3	84.98
Total Liabilities	154.14	158.28	168.65	219.54	176.68	258.1
Common Stock	1,365	1,365	1,365	1,365	1,365	1,365
Retained Earnings	806.53	890.95	969.08	960.2	905.47	833.11
Shareholders' Equity	2,172	2,256	2,334	2,325	2,270	2,198
Total Liabilities & Equity	2,326	2,414	2,503	2,545	2,447	2,456
Total Debt	41.47	52.33	61.86	99.09	42.71	45.69
Net Cash (Debt)	98.97	75.17	119.51	162.38	227.62	193.76
Net Cash Growth	-24.85%	-37.10%	-26.40%	-28.67%	17.48%	-34.14%
Net Cash Per Share	0.73	0.55	0.88	1.19	1.67	1.42
Filing Date Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Total Common Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Working Capital	819.8	865.35	914.23	925.05	986.45	930.44
Book Value Per Share	15.91	16.53	17.10	17.03	16.63	16.10
Tangible Book Value	2,170	2,255	2,333	2,324	2,269	2,197
Tangible Book Value Per Share	15.90	16.52	17.09	17.02	16.62	16.09
Land	342.77	342.77	342.77	342.77	342.77	340.78
Buildings	424.09	424.09	424.09	424.09	424.09	424.09
Machinery	1,149	1,149	1,090	1,072	998.72	980.87
Construction In Progress	322.86	317.67	343.47	274.25	178.47	121.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.